{"id":55059,"date":"2023-03-21T22:05:50","date_gmt":"2023-03-21T21:05:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/"},"modified":"2023-03-21T22:05:50","modified_gmt":"2023-03-21T21:05:50","slug":"simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/","title":{"rendered":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call"},"content":{"rendered":"
\n

\nConference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT<\/i> <\/b>\n<\/p>\n

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the financial markets on Wednesday, April 5, 2023.\n<\/p>\n

<\/a><\/p>\n

\nThe Company will host a conference call on April 5, 2023, at 5:00 p.m. Eastern Time. All interested parties are invited to join the live webcast by registering here<\/a>. The conference call can also be accessed by dialing 877-451-6152 (domestic) or 201-389-0879 (international) or by clicking on this Call me\u2122<\/a> link to request a return call. The webcast can be accessed on the Investors<\/a> page of the Simulations Plus website where it will also be available for replay approximately one hour following the call.\n<\/p>\n

\nAbout Simulations Plus<\/b>\n<\/p>\n

\nServing clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology\/toxicology, and population PK\/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com<\/a>. Follow us on LinkedIn<\/a> | Twitter<\/a> | YouTube<\/a>.\n<\/p>\n

\nEnvironmental, Social, and Governance (ESG)<\/b>\n<\/p>\n

\nWe focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSimulations Plus Investor Relations<\/span>
Ms. Renee Bouche
\n
661-723-7723
\n
renee.bouche@simulations-plus.com<\/a>\n<\/p>\n

\nHayden IR
\n
<\/span>Mr. Brian Siegel
\n
346-396-8696
\n
brian@haydenir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the financial markets on Wednesday, April 5, 2023. The … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55059","6":"format-standard","7":"category-industry"},"yoast_head":"\nSimulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the financial markets on Wednesday, April 5, 2023. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T21:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call\",\"datePublished\":\"2023-03-21T21:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/\"},\"wordCount\":295,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005464\\\/en\\\/1534621\\\/21\\\/SLP-Logo-Stacked.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/\",\"name\":\"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005464\\\/en\\\/1534621\\\/21\\\/SLP-Logo-Stacked.jpg\",\"datePublished\":\"2023-03-21T21:05:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005464\\\/en\\\/1534621\\\/21\\\/SLP-Logo-Stacked.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005464\\\/en\\\/1534621\\\/21\\\/SLP-Logo-Stacked.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend","og_description":"Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the financial markets on Wednesday, April 5, 2023. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-21T21:05:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call","datePublished":"2023-03-21T21:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/"},"wordCount":295,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/","url":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/","name":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg","datePublished":"2023-03-21T21:05:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230321005464\/en\/1534621\/21\/SLP-Logo-Stacked.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/simulations-plus-sets-date-for-second-quarter-fiscal-year-2023-earnings-release-and-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55059"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55059\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}